Cure All Super Speciality & Radiotherapy Centre Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 26-07-2024
- Paid Up Capital ₹ 9.24 Cr
as on 26-07-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 75.02 Cr
as on 26-07-2024
- Revenue -17.06%
(FY 2023)
- Profit -32.14%
(FY 2023)
- Ebitda -15.45%
(FY 2023)
- Net Worth -9.89%
(FY 2023)
- Total Assets -6.71%
(FY 2023)
About Cure All Super Speciality & Radiotherapy Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.24 Cr.
The company currently has active open charges totaling ₹75.02 Cr.
Santanu Chaudhuri, Punam Nangia, Neeta Nangia, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100MH2011PTC221753
- Company No.
221753
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cure All Super Speciality & Radiotherapy Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santanu Chaudhuri  | Director | 09-Sep-2011 | Current |
| Punam Nangia | Director | 09-Sep-2011 | Current |
| Neeta Nangia | Director | 20-Jul-2016 | Current |
| Mahesh Nangia | Director | 09-Sep-2011 | Current |
Financial Performance of Cure All Super Speciality & Radiotherapy Centre.
Cure All Super Speciality & Radiotherapy Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.06% decrease. The company also saw a substantial fall in profitability, with a 32.14% decrease in profit. The company's net worth dipped by a decrease of 9.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cure All Super Speciality & Radiotherapy Centre?
In 2023, Cure All Super Speciality & Radiotherapy Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nangia Automotive Private LimitedActive 14 years 10 monthsNeeta Nangia and Mahesh Nangia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 15 Mar 2024 | ₹13.15 Cr | Open |
Indian Overseas Bank Creation Date: 29 May 2021 | ₹6.99 Cr | Open |
Indian Overseas Bank Creation Date: 17 Oct 2020 | ₹5.00 Cr | Open |
How Many Employees Work at Cure All Super Speciality & Radiotherapy Centre?
Unlock and access historical data on people associated with Cure All Super Speciality & Radiotherapy Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure All Super Speciality & Radiotherapy Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure All Super Speciality & Radiotherapy Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
